The Lancet Oncology is the world’s leading clinical oncology journal, publishing high-quality, peer-reviewed original research (particularly clinical trial reports), reviews, commentary and opinion, weekly news, and commissions (typically in collaboration with societies, governments, NGOs, and academy centers). The journal is dynamic and educational, covering international themes of interest to clinical cancer specialists worldwide. The content includes subjects that promote clinical practice, question the status quo, advocate for health policy change, and address global oncology challenges.
Volume 24 (The Lancet Oncology):
- Issue 12 November 12, 2023 p1287-1442, e452-e519
- Issue 11 November 01, 2023 p1157-1286, e425-e451
- Issue 10 October 01, 2023 p1053-1156, e396-e424
- Issue 9 September 01, 2023 p945-1052, e356-e395
- Issue 8 August 01, 2023 p823-944, e324-e355
- Issue 7 July 01, 2023 p709-822, e285-e323
- Issue 6 June 01, 2023 p577-708, e229-e284
- Issue 5 May 01, 2023 p415-576, e187-e228
- Issue 4 April 01, 2023 p307-414, e145-e186
- Issue 3 March 01, 2023 p195-306, e103-e144
- Issue 2 February 01, 2023 p117-194, e58-e102
- Issue 1 January 01, 2023 p1-116, e1-e57
See Also: MD Anderson: Hematology & Oncology Board Review 2023
Reviews
There are no reviews yet.